Preclinical effectiveness of TB drug target validated

Scientists evaluating new drug targets against tuberculosis recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time. The new drug target is a protein called DNA gyrase B, found in bacteria that cause TB infections.

Read the whole article on Science Daily

More from Science Daily